Credit Suisse »

Zentalis Pharmaceuticals shares owned by Credit Suisse

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $741k 49k 15.15
2023-09-30 $1.0M 50k 20.06
2023-06-30 $1.7M 60k 28.21
2023-03-31 $643k 37k 17.20
2022-12-31 $752k 37k 20.14
2022-09-30 $820k 38k 21.72
2022-06-30 $996k 35k 28.15
2022-03-31 $904k 20k 46.07
2021-12-31 $1.5M 17k 84.01
2021-09-30 $826k 12k 66.59
2021-06-30 $658k 12k 53.74
2021-03-31 $519k 13k 40.00
2020-12-31 $2.0M 31k 62.50